We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BBH market cap is 405.15M. The company's latest EPS is USD 24.2799 and P/E is 6.55.
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 152k | ||||
Operating Income | 0 | ||||
Net Income | 13k |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 3.05M | 3.06M | 3.77M | 3.88M | 4.09M |
Operating Income | 0 | 0 | 0 | 0 | 0 |
Net Income | 117.15M | 117.2M | -181.28M | 45.87M | 61.84M |
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 118.09M | ||||
Total Liabilities | 9.45M | ||||
Total Equity | 108.64M |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 489.78M | 595.48M | 416.43M | 451.18M | 452.19M |
Total Liabilities | 4.33M | 5.36M | 2.12M | 202k | 196k |
Total Equity | 485.45M | 590.12M | 414.3M | 450.98M | 451.99M |
Quarter End | Mar 2012 | ||||
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | ||||
Investing | N/A | ||||
Financing | N/A |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Market Cap | 405.15M |
Price to Earnings Ratio | 6.55 |
Price to Sales Ratio | 99.16 |
Price to Cash Ratio | 842.53 |
Price to Book Ratio | 0.9 |
Dividend Yield | - |
Shares Outstanding | 2.55M |
Average Volume (1 week) | 5.8k |
Average Volume (1 Month) | 13.99k |
52 Week Change | -6.04% |
52 Week High | 183.6449 |
52 Week Low | 151.35 |
Spread (Intraday) | 0.22 (0.14%) |
Company Name | VanEck Biotech ETF |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.vaneck.com |
Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions